RDC (Radionuclide Drug Conjugate) is an innovative and rapidly evolving multifunctional radiopharmaceutical. Composed of four components, including radionuclide, chelator, linker, and targeting molecule, RDC can accurately identify the diseased cells, image the binding cells, and damage the tumor.
There are no reviews for this PDF.
There are no comments for this PDF.
You must log in to post a comment.
Log in
